External Source

Pfdd Workshop To Discuss Methodologic & Other Challenges Related To Patient Experience Data – Part 2

2025 3:07:33
Synopsis
On December 13, 2024, FDA hosted a virtual public workshop to discuss methodological challenges related to patient experience ...

You Might Also Like

PFDD Workshop to Discuss Methodologic & Other Challenges Related to Patient Experience Data – Part 3 51:23
Pfdd Workshop To Discuss Methodologic & Other Challenges Rel...
2025
PFDD Workshop to Discuss Methodologic & Other Challenges Related to Patient Experience Data – Part 1 1:56:00
Pfdd Workshop To Discuss Methodologic & Other Challenges Rel...
2025
2025 FDA/OSI Workshop: Advancing Osteosarcoma Drug Development 6:15:55
2025 Fda/osi Workshop: Advancing Osteosarcoma Drug Developme...
2025
EL-PFDD, Living with HCU Symptoms and Daily Impact: Panel 1 37:14
El-pfdd, Living With Hcu Symptoms And Daily Impact: Panel 1
2025
Data DIY 2 - Session 6: Patient Focused Drug Development 1:07:59
Data Diy 2 - Session 6: Patient Focused Drug Development
2023
Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #2 1:57:53
Public Meeting: Using Methods From Pfdd Guidance 1 And Guida...
2022
EL-PFDD, Current and future treatments: Panel 2 13:27
El-pfdd, Current And Future Treatments: Panel 2
2025
Public Meeting: Patient-Focused Drug Development for Autism (Part 2 of 2) 1:43:31
Public Meeting: Patient-focused Drug Development For Autism ...
2021
Day 2-Session 5-Regulatory Science Applied to DDCPs Intros, Talks, Panel, Closing Remarks 2:05:04
Day 2-session 5-regulatory Science Applied To Ddcps Intros, ...
2025
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 2 – Part 2 1:39:03
Advancing Generic Drug Development: Translating Science To A...
2024
AGDD 2024 | D1S09 - Q&A Discussion Panel 2 20:42
Agdd 2024 | D1s09 - Q&a Discussion Panel 2
2025
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.